Drug intelligence / Profile preview

carbaryl

Development stage
Unknown
Lead developer
Union Carbide
Modality
Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Carbaryl is a synthetic insecticide belonging to the carbamate chemical family. It was first synthesized in 1953 and has been widely used since the late 1950s for agricultural and residential pest control. Carbaryl acts as a reversible inhibitor of acetylcholinesterase, an enzyme essential for proper nervous system function in insects and mammals. By inhibiting this enzyme, carbaryl causes accumulation of acetylcholine at nerve synapses leading to overstimulation of the nervous system and eventual death in insects. In humans and other vertebrates, exposure can cause cholinesterase inhibition resulting in neurological symptoms such as headaches, muscle weakness, nausea, cramps, sweating, restlessness; severe poisoning may lead to paralysis or death[1][4][5]. Carbaryl is rapidly detoxified and eliminated by vertebrates but is highly toxic to many non-target species including beneficial insects (e.g., honeybees) and aquatic organisms[5]. It has been approved for use on over 100 crops in the US but banned or restricted in some regions such as the EU[5].

Brand names
SevinCarylderm
Other names
carbaryl
02

Targets

Acetylcholinesterase

Beyond the preview

Go deeper on carbaryl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carbaryl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call